Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
JCO Precision Oncology|October 5, 2020
Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint BlockadePeter G Miller, Christopher J Gibson, Arnav Mehta, et al.
Cancer Immunology Research|September 20, 2023
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint BlockadeSaba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint InhibitorsAi-Tram N Bui, Kevin Tyan, Anita Giobbie-Hurder, et al.
Biosensors & Bioelectronics|December 5, 1998
Description and demonstration of a CMOS amplifier-based-system with measurement and stimulation capability for bioelectrical signal transductionJ J Pancrazio, P P Bey, A Loloee, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in BRAF -Mutant MelanomaYingxiao Shi, Alexander Savchenko, Jan Christoph Brase, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2021
Long-term Overall Survival and Predictors in Anti-PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort StudyGirish S Naik, Elizabeth I Buchbinder, Justine V Cohen, et al.
Cancer Immunology Research|May 20, 2017
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint BlockadeJun Zhou, Kathleen M Mahoney, Anita Giobbie-Hurder, et al.
Cancer Immunology Research|December 23, 2016
Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint TherapyXinqi Wu, Anita Giobbie-Hurder, Xiaoyun Liao, et al.
Frontiers in Oncology|October 10, 2022
Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastasesAlexander Z Wei, Matan Uriel, Agata Porcu, et al.
Cancer Immunology Research|April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma PatientsF Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
Pageof 5